Table 1 IHC detection of HFGs by anti-HFG mAb in NATs and tumor tissues of patients with CRC
From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
Tissue | NAT | Tumor | ||
|---|---|---|---|---|
Patient no. | Score | % | Score | % |
1 | 0 | – | N/A | N/A |
2 | 0 | – | 1 | 40 |
3 | 0 | – | 2 | 100 |
4 | 0 | – | 2 | 80 |
5 | 0 | – | 2 | 80 |
6 | 0 | – | 1 | 30 |
7 | 0 | – | 2 | 30 |
8 | 3 | 80 | 3 | 100 |
9 | 0 | – | 1 | 60 |
10 | 1 | 10 | 2 | 60 |
11 | 3 | 95 | 2 | 15 |
12 | 2 | 70 | 3 | 100 |
13 | 0 | – | 0 | – |
14 | 0 | – | 2 | 100 |
15 | 1 | 15 | 1 | 100 |
16 | 3 | 60 | 2 | 100 |
17 | 0 | – | 1 | 60 |
18 | 0 | – | 2 | 90 |
19 | 3 | 70 | 3 | 100 |
20 | 0 | – | 1 | 10 |
21 | 0 | – | 0 | – |
22 | 0 | – | 1 | 20 |
23 | 0 | – | 1 | 80 |
24 | 3 | 100 | 2 | 75 |
25 | 3 | 30 | 2 | 100 |
26 | 0 | – | 1 | 40 |
27 | 0 | – | 2 | 100 |
28 | 0 | – | 0 | – |
29 | 0 | – | 2 | 80 |
30 | 0 | – | 1 | 20 |